Business StandardCenter·
Centre to cap trade margins on non-scheduled cancer drugs at 30%
Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups
Read at Business Standard →
Business · 1 sources covering this
Centre to cap trade margins on non-scheduled cancer drugs at 30%
Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/a8c75e27893ca526c89ba577bc8d42f4912dbd2e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Centre to cap trade margins on non-scheduled cancer drugs at 30%"></iframe>
